Expects full year positive adjusted EBITDA and adjusted EBITDA growth in 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BLFS:
- BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results
- BLFS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- BioLife Solutions price target raised to $20 from $15 at Lake Street
- BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue
- BioLife Solutions sees FY23 revenue $143.3M, consensus $144.37M
